arginine vasopressin has been researched along with Delusional Disorder in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sharifi, N; Spelman, L; Thakore, JH; Walsh, P | 1 |
Bakharev, VD; Chipens, GI; Papsuevich, OS; Tikhomirov, SM | 1 |
Beckmann, H; Gattaz, WF; Lang, RE | 1 |
1 trial(s) available for arginine vasopressin and Delusional Disorder
Article | Year |
---|---|
Male patients with paranoid schizophrenia have greater ACTH and cortisol secretion in response to metoclopramide-induced AVP release.
Topics: Adrenocorticotropic Hormone; Adult; Arginine Vasopressin; Dopamine Antagonists; Humans; Hydrocortisone; Male; Metoclopramide; Psychiatric Status Rating Scales; Schizophrenia, Paranoid | 2005 |
2 other study(ies) available for arginine vasopressin and Delusional Disorder
Article | Year |
---|---|
[Use of vasopressin the treatment of the paranoid form of schizophrenia].
Topics: Adult; Antipsychotic Agents; Arginine Vasopressin; Follow-Up Studies; Humans; Male; Middle Aged; Schizophrenia, Paranoid; Syndrome | 1984 |
Vasopressin--oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls.
Topics: Adult; Arginine Vasopressin; Female; Haloperidol; Humans; Male; Oxytocin; Psychiatric Status Rating Scales; Radioimmunoassay; Schizophrenia, Paranoid; Schizophrenic Psychology | 1985 |